-- Boehringer Has 25% of Its Research in Biotech, Sueddeutsche Says
-- B y   J u l i e   C r u z
-- 2012-03-27T07:31:41Z
-- http://www.bloomberg.com/news/2012-03-27/boehringer-has-25-of-its-research-in-biotech-sueddeutsche-says.html
A quarter of  Boehringer Ingelheim
GmbH (BING) â€™s research projects are based on biotechnology,
Sueddeutsche Zeitung reported, citing an interview with Chief
Executive Officer Andreas Barner.  The company is circumspect about acquisitions, Barner told
the newspaper.  To contact the reporter on this story:
Julie Cruz in Frankfurt via 
 jcruz6@bloomberg.net   To contact the editor responsible for this story:
Sara Marley at   smarley1@bloomberg.net  